-+ 0.00%
-+ 0.00%
-+ 0.00%

Cardiol Therapeutics Q3 EPS $(0.09), Inline

Benzinga·11/13/2025 22:35:14
Listen to the news
Cardiol Therapeutics (NASDAQ:CRDL) reported quarterly losses of $(0.09) per share which met the analyst consensus estimate. This is a 30.77 percent increase over losses of $(0.13) per share from the same period last year.